drugset / Trial / NCT00221962
Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
Phase 4
Completed
23 enrolled
University Hospitals Cleveland Medical Center
Bristol-Myers Squibb · collab
NaSingle-groupOpen-labelTreatment
Summary
To look at the cognitive effects of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder. To examine the safety, effectiveness and tolerability of abilify in children with a primary diagnosis of Attention Deficit Hyperactivity Disorder.
Timeline
- Start
- 2005-04
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | — |